
Neotiv GmbH closes €10m seed financing
In light of the high-profile Phase III Clarity trial results of Esai/Biogen's Alzheimer's protofibril inhibitor lecanemab, early diagnosis of...

A ray of hope in leukaemia
In 2021, Alyssa, a 13-year-old girl from Leicester, after a long struggle with what her family thought to be colds, viruses, and general tiredness,...

EpiEndo Pharmaceuticals pushes COPD candidate
The Icelandic inflammation specialist received regulatory approval for its Phase IIa trial of Barriolide™ (EP395) in patients with Chronic...

Evidence of deliberate climate damage
For decades, some members of the fossil fuel industry tried to convince the public that a causative link between fossil fuel use and climate warming...

Abionyx Pharma announces success in fighting sepsis-triggered AKI
After AM-Pharma’s human recombinant alkaline phosphatase, ilofotase alfa, missed the endpoint of improving overall survival in patients with...

Collaboration to develop mRNA vaccine against betacoronaviruses
Ethris GmbH a German company specialising in the development of mRNA vaccines, announced their collaboration with DIOSynVax Ltd., an English biotech...

Fungal skin replaces plastics in electronics
In a proof-of-concept study, Doris Danninger and colleagues demonstrate that fungal mycelium skins can be grown and processed to serve as substrates...